Form 4 for ENTX Entera Bio Ltd.
Accepted 2025-04-03 00:00:00 ET · period of report 2025-04-01 · accession 0001178913-25-001192 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-03 | 2025-04-01 | ENTX | LIEBERMAN GERALD M | Dir | M - OptEx | $1.00 | +24.0K | 300.2K | +9% | +$24.0K |
| D | 2025-04-03 | 2025-04-01 | ENTX | LIEBERMAN GERALD M | Dir | M - OptEx | $0.00 | -24.0K | 28.5K | -46% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares, par value NIS 0.0000769 per share | 2025-04-01 | M | A | 23,952 | $1.00 | 300,160 | D | — | — | |
| 2 | Derivative | Warrant (right to buy) | 2025-04-01 | M | D | 23,952 | $0.00 | 28,509 | D | $1.00 · 2023-12-22 to 2028-12-22 | 23,952 Ordinary Shares, par value NIS 0.0000769 per share |